SCHEMBL4670786

SCHEMBL4670786

CC(C)C(NS(=O)(=O)N1CCC(Oc2ccc(Cl)cn2)CC1)C(=O)O

nearest known ligand 0.82

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP1 P03956 2/20 0.82
FPR2 P25090 2/20 0.51
PROKR1 Q8TCW9 2/20 0.51
MMP2 P08253 2/20 0.40
MMP3 P08254 1/20 0.40
MMP7 P09237 1/20 0.40
MMP9 P14780 1/20 0.40
MMP13 P45452 1/20 0.40
ALDH1A1 P00352 1/20 0.40
LIPE Q05469 1/20 0.40
HRH3 Q9Y5N1 2/20 0.39
IP6K1 Q92551 1/20 0.39
NAMPT P43490 2/20 0.38
GPR119 Q8TDV5 2/20 0.38
TDO2 P48775 1/20 0.38
PTGDR Q13258 1/20 0.37
LMNA P02545 2/20 0.37
GAA P10253 1/20 0.37
ACACB O00763 1/20 0.37
TSHR P16473 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4670721 1.00 MMP1 (0.82) MMP1FPR2PROKR1MMP2MMP3
SCHEMBL4671107 0.91 MMP1 (0.81) MMP1FPR2PROKR1ALDH1A1LIPE
SCHEMBL4671105 0.91 MMP1 (0.81) MMP1FPR2PROKR1ALDH1A1LIPE
SCHEMBL4670756 0.90 MMP1 (1.00) MMP1FPR2PROKR1ALDH1A1LIPE
SCHEMBL4670757 0.90 MMP1 (1.00) MMP1FPR2PROKR1ALDH1A1LIPE
SCHEMBL4673324 0.84 MMP1 (0.59) MMP1FPR2PROKR1MMP2MMP3
SCHEMBL4673327 0.84 MMP1 (0.59) MMP1FPR2PROKR1MMP2MMP3
SCHEMBL4673631 0.81 MMP1 (0.77) MMP1FPR2PROKR1ALDH1A1LIPE
SCHEMBL4673634 0.81 MMP1 (0.77) MMP1FPR2PROKR1ALDH1A1LIPE
SCHEMBL2776856 0.78 MMP1 (0.59) MMP1FPR2PROKR1LIPENAMPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0958287-B2 SULFAMIDE-METALLOPROTEASE INHIBITORS HOFFMANN LA ROCHE (CH) 2008-04-09 EP disclosed
EP-0958287-B1 SULFAMIDE-METALLOPROTEASE INHIBITORS HOFFMANN LA ROCHE (CH) 2002-09-11 EP disclosed
US-6376506-B1 REACTING SULFAMOYL OXAZOLIDONE WITH (1,2,3,4)-TETRAHYDRO-BETA-CARBOLINE TO FORM INHIBITOR; USED TO TREAT ARTHRITIS, OSTEOPOROSIS, PERIODONTAL DISEASE, CARDIOVASCULAR DISEASES, MULTIPLE SCLEROSIS, AND TUMORS SYNTEX (U.S.A.) LLC 2002-04-23 US disclosed
US-6143744-A Sulfamide-metalloprotease inhibitors SYNTEX (U.S.A.) INC. (US) 2000-11-07 US disclosed
US-6130220-A ENZYME INHIBITORS SYNTEX (USA) INC. (US) 2000-10-10 US disclosed
US-5998412-A ANTIARTHRITIC AGENTS; OSTEOPOROSIS SYNTEX (U.S.A.) INC. (US) 1999-12-07 US disclosed
EP-0958287-A1 SULFAMIDE-METALLOPROTEASE INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 1999-11-24 EP disclosed
WO-1998032748-A1 SULFAMIDE-METALLOPROTEASE INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 1998-07-30 WO disclosed